1. Home
  2. MDGL vs ZWS Comparison

MDGL vs ZWS Comparison

Compare MDGL & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • ZWS
  • Stock Information
  • Founded
  • MDGL 2011
  • ZWS 1891
  • Country
  • MDGL United States
  • ZWS United States
  • Employees
  • MDGL N/A
  • ZWS N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • ZWS Industrial Machinery/Components
  • Sector
  • MDGL Health Care
  • ZWS Industrials
  • Exchange
  • MDGL Nasdaq
  • ZWS Nasdaq
  • Market Cap
  • MDGL 6.8B
  • ZWS 5.9B
  • IPO Year
  • MDGL N/A
  • ZWS 2012
  • Fundamental
  • Price
  • MDGL $275.26
  • ZWS $36.17
  • Analyst Decision
  • MDGL Strong Buy
  • ZWS Buy
  • Analyst Count
  • MDGL 10
  • ZWS 6
  • Target Price
  • MDGL $420.63
  • ZWS $37.67
  • AVG Volume (30 Days)
  • MDGL 335.5K
  • ZWS 674.2K
  • Earning Date
  • MDGL 05-01-2025
  • ZWS 07-29-2025
  • Dividend Yield
  • MDGL N/A
  • ZWS 0.99%
  • EPS Growth
  • MDGL N/A
  • ZWS 40.41
  • EPS
  • MDGL N/A
  • ZWS 0.98
  • Revenue
  • MDGL $317,383,000.00
  • ZWS $1,581,500,000.00
  • Revenue This Year
  • MDGL $285.43
  • ZWS $4.31
  • Revenue Next Year
  • MDGL $63.77
  • ZWS $4.71
  • P/E Ratio
  • MDGL N/A
  • ZWS $37.69
  • Revenue Growth
  • MDGL N/A
  • ZWS 3.22
  • 52 Week Low
  • MDGL $200.63
  • ZWS $27.74
  • 52 Week High
  • MDGL $377.46
  • ZWS $41.15
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 38.56
  • ZWS 55.55
  • Support Level
  • MDGL $265.39
  • ZWS $35.07
  • Resistance Level
  • MDGL $275.54
  • ZWS $37.01
  • Average True Range (ATR)
  • MDGL 11.39
  • ZWS 0.70
  • MACD
  • MDGL -1.08
  • ZWS -0.16
  • Stochastic Oscillator
  • MDGL 24.12
  • ZWS 40.71

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.

Share on Social Networks: